We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.77%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.31%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Live Nation Entertainment
LYV
$41.9B
| $28.7M | 0.15% |
1,163,741
-113,938
| -9% | -$2.56M |
|
152
Texas Instruments
TXN
$249B
| $28.2M | 0.14% |
+589,198
| New | +$27.5M |
|
153
Marathon Petroleum
MPC
$92.3B
| $27.7M | 0.14% |
+708,432
| New | +$31.3M |
|
|
154
Gilead Sciences
GILD
$161B
| $27.6M | 0.14% |
333,196
-3,182,295
| -91% | -$248M |
|
|
ERF
155
DELISTED
Enerplus Corporation
ERF
| $27.3M | 0.14% |
1,091,096
+1,044,243
| +2,229% | +$23.1M |
|
156
Pinnacle West Capital
PNW
$12.2B
| $27.3M | 0.14% |
472,547
+291,271
| +161% | +$16.1M |
|
157
Telus
TU
$14.8B
| $27.1M | 0.14% |
+1,452,632
| New | +$26.6M |
|
158
Applied Materials
AMAT
$409B
| $27M | 0.14% |
+1,198,440
| New | +$24.4M |
|
|
FSL
159
DELISTED
FREESCALE SEMICONDUCTOR LTD
FSL
| $26.9M | 0.14% |
1,144,773
+172,450
| +18% | +$4M |
|
|
RDS.B
160
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $26.7M | 0.14% |
307,110
+304,042
| +9,910% | +$25.3M |
|
|
PWE
161
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $26.6M | 0.14% |
2,722,911
+2,467,815
| +967% | +$22.9M |
|
162
Ericsson
ERIC
$33.1B
| $26.4M | 0.14% |
2,183,148
-11,098,249
| -84% | -$138M |
|
|
TQNT
163
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $26.1M | 0.13% |
1,652,862
+1,424,441
| +624% | +$21.1M |
|
|
VTLE
164
DELISTED
Vital Energy
VTLE
| $25.8M | 0.13% |
41,655
+25,995
| +166% | +$14.7M |
|
165
Boston Scientific
BSX
$70.8B
| $25.5M | 0.13% |
1,998,590
-6,439,039
| -76% | -$83.7M |
|
166
Enbridge
ENB
$118B
| $25.2M | 0.13% |
+529,720
| New | +$25.1M |
|
167
Altria Group
MO
$113B
| $24.9M | 0.13% |
593,085
-291,464
| -33% | -$11.7M |
|
168
Broadcom
AVGO
$1.84T
| $24.8M | 0.13% |
3,442,300
+2,764,820
| +408% | +$18.6M |
|
169
Banco Santander Chile
BSAC
$16.2B
| $24.8M | 0.13% |
937,710
+923,650
| +6,569% | +$23M |
|
|
CB
170
DELISTED
CHUBB CORPORATION
CB
| $24.5M | 0.13% |
+266,240
| New | +$24.5M |
|
171
Novartis
NVS
$292B
| $24.1M | 0.12% |
+297,414
| New | +$23.4M |
|
172
Vermilion Energy
VET
$1.76B
| $23.9M | 0.12% |
342,687
+258,528
| +307% | +$17.2M |
|
|
SPIL
173
DELISTED
Siliconware Precision Industries Co Ltd
SPIL
| $23.8M | 0.12% |
2,900,006
+742,792
| +34% | +$5.58M |
|
174
Arch Capital
ACGL
$34.1B
| $23.8M | 0.12% |
1,242,111
+1,174,113
| +1,727% | +$22.4M |
|
175
Voya Financial
VOYA
$9.09B
| $23.6M | 0.12% |
648,661
-498,982
| -43% | -$17.8M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.